Effects of primary chemotherapy on biological parameters of locally advanced breast cancer

Annals of the New York Academy of Sciences

Volumn 784, Issue , 1996, Pages 419-426

  Collecchi, P ^a,b   Giannessi, P G ^a,b   Baldini, E ^a,b   Naccarato, A G ^a,b   Passoni, A ^a,b   Bevilacqua, G ^a,b   Conte, P F ^a,b  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PROTEIN BCL 2; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; BREAST CANCER; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MASTECTOMY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0029883334     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb16256.x     Document Type: Conference Paper

References (21)

1. 3H-Thymidine labelling index as a prognostic indicator in node-positive breast cancer. J. Clin. Oncol. 8: 1-6.
2. AMADORI, D., A. VOLPI, A. CALLEA, L. AMADUCCI, S. MORGAGNI, E. MAGNI & O. NANNI. 1994. Clinical relevance of cell kinetics in breast cancer. Ann. N.Y. Acad. Sci. 689: 186-192.
3. GARDIN, G., A. ALAMA, R. ROSSO, E. CAMPORA, L. REPETTO, P. PRONZATO, L. MERLINI, C. NASO, A. CAMORIANO, R. MEAZZA, F. BARBIERI, E. BALDINI, P. G. GIANNESSI & P. F. CONTE. 1994. Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer. Breast Cancer Res. Treat. 32: 311-318.
4. DAIDONE, M. G., R. SILVESTRINI, A. LUISI, M. MASTORE, E. BENINI, S. VENERONI, C. BRAMBILLA, L. FERRARI, M. GRECO, S. ANDREOLA & U. VERONESI. 1995. Changes in biological markers after primary chemotherapy for breast cancer. Int. J. Cancer 61: 301-305.
5. DAIDONE, M. G., R. SILVESTRINI, B. VALENTINIS, L. FERRARI & C. BARTOLI. 1991. Changes in cell kinetics induced by primary chemotherapy in breast cancer. Int. J. Cancer 47: 380-383.
6. OSBORNE, C. K., D. R. CLEMMONS & C. L. ARTEAGA. 1990. Regulation of breast cancer growth by insulin-like growth factors. J. Steroid Biochem. Mol. Biol. 37: 805-809.
7. PEYRAT, J. P., P. H. BONNETERRE, H. VENNIN, H. JAMMES, R. BEAUSCART, B. HECQUET, J. DJIANE, J. LEFEBVRE & A. DEMAILLE. 1990. Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors. J. Steroid Biochem. Mol. Biol. 37: 823-827.
8. BONNETERRE, P., J. P. PEYRAT, R. BEUSCART & A. DEMAILLE. 1990. Prognostic significance of IGF1 receptors in human breast cancer. Cancer Res. 50: 6931-6935.
9. FISHER, T. C., A. E. MILNER, C. D. GREGOTY, G. W. JAKMAN, G. W. AHERNE, J. A. HARTELY, C. DIVE & J. A. HICKMAN. 1993. Bc12 modulation and apoptosis induced by anticancer drug-resistance pathways. Cancer Res. 53: 3321-3326.
10. SENTMAN, C. L., J. R. SHUTTER, D. HOCKENBERY, O. KANAGAWA & S. J. KORSMEYER. 1991. Bc12 inhibits multiple forms of apoptosis, but not negative selection in thymocytes. Cell 67: 879-888.
11. LU, Q. L., G. ELIA, S. LUCAS & J. A. THOMAS. 1993. Bc12 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int. J. Cancer 53: 29-35.
12. SILVESTRINI, R., S. VERONESI, M. G. DAIDONE, E. BENINI, P. BORACCHI, M. MEZZETTI, G. DI FRONZO, F. RILKE & U. VERONESI. 1994. The bc12 protein: a prognostic indicator strongly related to p53 protein in lymph-node negative breast cancer patients. J. Natl. Cancer Inst. 86: 499-504.
13. GARDIN, G., R. ROSSO, E. CAMPORA, L. REPETTO, C. NASO, G. CANAVESE, A. CATTURICH, R. CORVO, M. GUENZI, P. PRONZATO, E. BALDINI & P. F. CONTE. 1995. Locally advanced non-metastatic breast cancer: analysis of prognostic factor in 125 patients homogeneously treated with a combined modality approach. Eur. J. Cancer 31A(9): 1428-1433.
14. O'REILLY, S. M., R. S. CAMPLEJHON, R. D. RUBENS & M. A. RICHARDS. 1992. DNA flow cytometry and response to preoperative chemotherapy for primary breast cancer. Eur. J. Cancer 28: 681-683.
15. REMVIKOS, Y., M. JOUVE, P. BEUZEBOC, P. VIENL, H. MAGDELENAT & P. POUILLART. 1993. Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates. Eur. J. Cancer 29A: 1843-1848.
16. BONADONNA, G., V. VERONESI, C. BRAMBILLA, L. FERRARI, A. LUINI, M. GRECO, C. BARTOLI, G. COOPMANS DE YOLD, R. ZUCALI, F. RILKE, S. ANDREOLA, R. SILVESTRINI, G. DI FRONZO & P. VALAGUSSA. 1990. Primary chemotherapy to avoid mastectomy in tumors with diameters of 3 centimeters or more. J. Natl. Cancer Inst. 82: 1539-1545.
17. SILVESTRINI, R., M. G. DAIDONE, P. VALAGUSSA, B. SALVADORI, D. ROVINI & G. BONADONNA. 1987. Cell kinetics and prognosis in locally advanced breast cancer. Cancer Treat. Rep. 70: 375-379.
18. BASERGA, R., C. SELL, P. PORCU & M. RUBINI. 1994. The role of the IGF-1 receptor in the growth and transformation of mammalian cells. Cell Proliferation 27: 63-71.
19. PIETROKOWSKI, Z., C. SELL, R. LAMMERS, A. ULLRICH & R. BASERGA. 1992. Roles of insulin-like growth factor 1 (IGF-1) and its receptor in epidermal growth factor-stimulated growth of the 3T3 cells. Mol. Cell. Biol. 12: 3883-3889.
20. KERR, J. F. R. & C. M. WINTERFORD. 1994. Apoptosis. Cancer 73: 2013-2026.
21. RASBRIDGE, S. A., C. E. GILLET, A. M. SEYMOUR, K. PATEL, M. A. RICHARDS, R. D. RUBENS & R. R. MILLIS. 1994. The effects of chemotherapy on morphology, cellular proliferation, apoptosis, and oncoprotein expression in primary breast carcinoma. Br. J. Cancer 70: 335-341.